» Articles » PMID: 9051373

Stable Glomerular Filtration Rate in Normotensive IDDM Patients with Stable Microalbuminuria. A 5-year Prospective Study

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 1997 Mar 1
PMID 9051373
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the long-term course of glomerular filtration rate (GFR) in IDDM patients with microalbuminuria in order to identify patients with stable or declining kidney function over a 5-year study.

Research Design And Methods: Forty normotensive (129 +/- 11/80 +/- 8 mmHg) IDDM patients with persistent microalbuminuria (mean urinary albumin excretion [UAE] 84 mg/24 h [range 30-300]) were followed prospectively for 5 years of clinical examinations that included the measurement of GFR (51Cr-labeled EDTA clearance) at least once a year. The mean GFR at baseline was 120 +/- 18 ml x min-1.1 x 73 m-2.

Results: Using multiple regression analysis, the rate of decline in GFR was independently correlated to onset of diabetic nephropathy (P < 0.001) and systolic blood pressure (sBP) at baseline (P < 0.05). Increase in UAE was correlated to the mean HbA1c during the observation period. Out of 40 patients, 14 progressed to diabetic nephropathy (UAE > 300 mg/24 h). These patients had a significant reduction in GFR (mean -2.2 +/- 3.8 ml x min-1 x year-1; P = 0.05), while GFR remained stable in the remaining 26 patients with nonprogressive microalbuminuria (change in GFR 0.5 +/- 2.1 ml x min-1 x year-1; NS). The difference in the rate of decline of GFR was significant (mean 2.7 ml x min-1 x year-1; P < 0.05).

Conclusions: Normotensive IDDM patients with nonprogressive microalbuminuria have a stable GFR. Progression of UAE to diabetic nephropathy heralds a progressive loss of kidney function. Efforts should be made to prevent the progression from microalbuminuria to diabetic nephropathy in every IDDM patient with microalbuminuria.

Citing Articles

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Tonneijck L, Muskiet M, Smits M, van Bommel E, Heerspink H, van Raalte D J Am Soc Nephrol. 2017; 28(4):1023-1039.

PMID: 28143897 PMC: 5373460. DOI: 10.1681/ASN.2016060666.


In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

Perkins B, Ficociello L, Roshan B, Warram J, Krolewski A Kidney Int. 2009; 77(1):57-64.

PMID: 19847154 PMC: 3725722. DOI: 10.1038/ki.2009.399.


Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria.

Mathiesen E, Hommel E, Hansen H, Smidt U, Parving H BMJ. 1999; 319(7201):24-5.

PMID: 10390455 PMC: 28150. DOI: 10.1136/bmj.319.7201.24.